Medicare Enrolled
Dr. Rachel Quinby-Graves, M.D.
Dermatology · Frisco, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Quinby-Graves from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Quinby-Graves?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Quinby-Graves
Dr. Rachel Quinby-Graves is a dermatology specialist in Frisco, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Quinby-Graves performed 1,362 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Quinby-Graves received a total of $17,471 from 48 pharmaceutical and/or device companies across 756 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Quinby-Graves is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ 1,362 Medicare services
$17,471 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗1,362
Medicare services
Bottom 29% in TX for dermatology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
Not available
Unique patients (not deduplicated)
$47
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
515 | $5 | $18 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
165 | $60 | $177 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
157 | $34 | $132 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
122 | $68 | $202 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
121 | $85 | $251 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
88 | $83 | $223 |
| Additional skin growth biopsy Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session. |
62 | $41 | $101 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
35 | $83 | $218 |
| Intermediate wound repair, 2.6-7.5 cm A medical procedure to close a wound on the scalp, underarms, trunk, arms, or legs that measures between 2.6 and 7.5 centimeters. This type of repair involves cleaning the wound and stitching it closed to promote healing. |
31 | $244 | $598 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
24 | $113 | $335 |
| Surgical removal of skin cancer, 1.1-2.0 cm Surgical excision of a cancerous skin growth measuring between 1.1 and 2.0 centimeters on the body, arms, or legs. |
22 | $103 | $481 |
| Destruction of cancer skin growth, 1.1-2.0 cm Removal of a cancerous skin growth on the trunk, arms, or legs that measures between 1.1 and 2.0 centimeters. |
20 | $127 | $351 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$17,471
Total received (2018-2024)
Avg $2,496/year across 7 years
Top 15% in TX for dermatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
48
Companies
756
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,298
2023
$2,331
2022
$1,975
2021
$2,117
2020
$2,038
2019
$3,080
2018
$3,632
Payments by company (2024)
ABBVIE INC.
$730
Regeneron Healthcare Solutions, Inc.
$223
GENZYME CORPORATION
$211
Amgen Inc.
$203
Dermavant Sciences, Inc.
$151
SUN PHARMACEUTICAL INDUSTRIES INC.
$142
Janssen Biotech, Inc.
$118
PFIZER INC.
$92
Incyte Corporation
$76
Novartis Pharmaceuticals Corporation
$66
Arcutis Biotherapeutics, Inc.
$56
Lilly USA, LLC
$50
Ortho Dermatologics, a division of Bausch Health US, LLC
$47
UCB, Inc.
$42
Galderma Laboratories, L.P.
$32
LEO Pharma Inc.
$23
Almirall LLC
$18
Genentech USA, Inc.
$18
Top 3 companies account for 50.7% of 2024 payments
All-time payments by company (2018-2024) ›
Ortho Dermatologics, a division of Bausch Health US, LLC
$1,821
ABBVIE INC.
$1,529
Regeneron Healthcare Solutions, Inc.
$1,330
GENZYME CORPORATION
$1,138
Encore Dermatology Inc.
$1,075
Janssen Biotech, Inc.
$992
Novartis Pharmaceuticals Corporation
$842
Lilly USA, LLC
$807
Sun Pharmaceutical Industries Inc.
$794
AbbVie, Inc.
$724
Galderma Laboratories, L.P.
$701
AbbVie Inc.
$641
SUN PHARMACEUTICAL INDUSTRIES INC.
$582
Amgen Inc.
$391
Mayne Pharma Inc.
$355
LEO Pharma Inc.
$325
Allergan, Inc.
$287
Incyte Corporation
$282
PFIZER INC.
$270
Journey Medical Corporation
$216
NOVARTIS PHARMACEUTICALS CORPORATION
$212
MAYNE PHARMA INC.
$205
EPI Health, LLC
$202
VYNE Pharmaceuticals Inc.
$196
UCB, Inc.
$187
Celgene Corporation
$168
Dermavant Sciences, Inc.
$151
Genentech USA, Inc.
$128
Janssen Scientific Affairs, LLC
$125
Taro Pharmaceuticals USA, Inc.
$118
Almirall LLC
$118
Arcutis Biotherapeutics, Inc.
$102
DERMIRA, INC.
$85
PruGen, Inc. Pharmaceuticals
$73
E.R. Squibb & Sons, L.L.C.
$46
Glenmark Therapeutics Inc.
$33
Exeltis, USA Inc.
$29
Boehringer Ingelheim Pharmaceuticals, Inc.
$26
Nabriva Therapeutics, plc
$25
Sandoz Inc.
$21
Kyowa Kirin, Inc.
$19
TARO PHARMACEUTICALS USA, INC.
$17
Paratek Pharmaceuticals, Inc.
$16
Stemline Therapeutics Inc.
$15
Mission Pharmacal Company
$15
Aclaris Therapeutics, Inc.
$14
Promius Pharma LLC
$12
Mylan Pharmaceuticals Inc.
$11
Top 3 companies account for 26.8% of all-time payments
Associated products mentioned in payments ›
0.25% · ABSORICA · ABSORICA (isotretinoin) · ABSORICA LD · ADBRY · AKLIEF · ALTRENO · AMZEEQ · ARAZLO · Absorica LD · Aczone · BLU-U · BOTOX · BOTOX COSMETIC · Bensal HP · Bimzelx · CLODERM · COSENTYX · Cabtreo · Cimzia · Clindamycin Phosphate and Benzoyl Peroxide · DORYX · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · ELZONRIS · ENSTILAR · EPIDUO FORTE · EUCRISA · Eletone · Erivedge · Exelderm · FINACEA · HALOG (Halcinonide Cream · HALOG OINTMENT (Halcinonide Ointment · HUMIRA · Humira · ILUMYA · ILUMYA (tildrakizumab-asmn) injection · Ilumya · Impoyz · JUBLIA · KERYDIN · Klisyri · LIBTAYO · LITFULO · Mupirocin Cream · NUZYRA · Neocera · ODOMZO · OLUMIANT · ONEXTON · OPZELURA · ORACEA · Odomzo · Otezla · PICATO · POTELIGEO · QBREXZA · REMICADE · RHOFADE · RINVOQ · SILIQ · SKYRIZI · SOOLANTRA · SPEVIGO · STELARA · Seysara · Sitavig · Sivextro · Sotyktu · TALTZ · TOPICORT (desoximetasone) Topical Spray · TREMFYA · TargaDox · Tremfya · Trianex · ULTRAVATE · ULTRAVATE (halobetasol propionate) lotion · USP) 0.1% · VTAMA · WYNZORA · Winlevi · ZILXI · Zoryve
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Dermatologists in nearby ZIP areas
156
County median income
$108,185
Nearest hospital to ZIP centroid (approximate)
TEXAS HEALTH HOSPITAL FRISCO
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Quinby-Graves is a clinical cardiology specialist, with moderate Medicare volume, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Quinby-Graves experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Quinby-Graves performed 515 destruction of precancerous skin growths, 2-14 services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Quinby-Graves receive payments from pharmaceutical companies?
Yes. Dr. Quinby-Graves received a total of $17,471 from 48 companies across 756 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Quinby-Graves's costs compare to other dermatologists in Frisco?
Dr. Quinby-Graves's average Medicare payment per service is $47. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Quinby-Graves) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Dermatologists in Frisco
Browse dermatologists in Frisco ranked by procedure volume and transparency data.
Highest volume
Top Dermatologists in TX
Dermatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Dermatologists in TX
Which TX dermatologists receive the most from drug and device companies.
By company
Ortho Dermatologics, a division of Bausch Health US, LLC Payments to Doctors
See all physicians who received payments from Ortho Dermatologics, a division of Bausch Health US, LLC.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Regeneron Healthcare Solutions, Inc. Payments to Doctors
See all physicians who received payments from Regeneron Healthcare Solutions, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology